类风湿关节炎韧性与健康生活方式(RA-HEAL试验):一项随机、平行组、安慰剂对照临床试验方案
RA-HEAL试验为实用性随机对照试验,比较结构化多学科生活方式干预与最佳实践常规护理中自主活动对类风湿关节炎患者的效果。干预组接受临床健康心理学家韧训、运动生理学家运动计划、营养师饮食教育、戒烟及行为改变支持;主要结局为6个月时健康相关生活质量。
要点
- 干预组接受20周多模态干预,包括韧性训练、运动、饮食教育、戒烟及行为改变支持。
- 对照组接受符合标准最佳实践护理的书面健康生活方式信息。
- 主要结局为6个月时健康相关生活质量,次要结局包括效果持续至2年及成本效用。
核心结论
- RA-HEAL检验包含临床心理学家正式韧性训练及地中海饮食、运动、戒烟和行为改变支持的定制干预,在6个月时对健康相关生活质量的效果是否大于当前最佳实践环境中的书面建议。
研究设计与样本
- 实用性随机对照试验,平行组设计,比较结构化多学科生活方式干预与最佳实践常规护理中自主活动。
- 干预为期20周,包括临床健康心理学家主导的韧性训练、运动生理学家主导的运动计划、营养师饮食教育、戒烟计划(适用时)及心理学家主导的行为改变支持。
- 对照组接受符合标准最佳实践护理的书面健康生活方式信息。
- 主要结局为6个月时健康相关生活质量;与澳大利亚自身免疫性关节炎生物样本库协作组织(A3BC)关联,支持干预后至24个月每6个月随访数据和生物采样及健康数据收集 linkage。
- 试验注册号ACTRN12625000050459,ANZCTR,注册日期2025年1月20日。
主要发现
- 原文为试验方案,未报告结局数据。
关键数值与推荐
- 主要结局为6个月时健康相关生活质量。
- 次要结局包括分析干预或最佳实践常规护理效果持续至2年及成本效用。
- 干预针对发病12个月内的类风湿关节炎患者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The importance of self-management strategies that optimise physical health and mental health in the management of rheumatoid arthritis (RA) is recognised, but access to multidisciplinary teams to support this can be challenging. Furthermore, evidence for the impact of multidisciplinary interventions, especially in early RA, is lacking. METHODS: The Resilience and Healthy Lifestyle for Rheumatoid Arthritis (RA-HEAL) Trial is a pragmatic RCT that aims to compare the effects of a structured multidisciplinary lifestyle intervention with self-directed activities in best-practice usual care. The 20-week multi-modal intervention incorporates structured resilience training conducted by a clinical health psychologist (CHP), followed by an exercise physiologist (EP)-led exercise programme, dietary education conducted by a dietitian nutritionist (DN), a smoking cessation programme (where applicable) and psychologist-led behaviour-change support. The comparison group will receive written information on a healthy lifestyle in accordance with standard best practice care. The primary outcome is health-related quality of life (QoL) at 6 months. DISCUSSION: RA-HEAL tests whether a tailored intervention including formal resilience training with a clinical psychologist followed by Mediterranean diet, exercise, smoking cessation and behaviour change support has a greater effect on health-related QoL at 6 months than written advice given in current best-practice settings. QoL is a composite endpoint that is highly valued by patients with RA. RA-HEAL is unique in that it targets RA within 12 months of onset. RA-HEAL's linkage with the Australian Autoimmune Arthritis Biobank Cooperative (A3BC) supports 6 monthly follow-up data and biosampling to 24 months post-intervention and linkage to health data collections, creating a valuable resource for future research and the potential to determine medium and long-term effects of behaviour change. In its secondary outcomes, RA-HEAL will analyse the longevity of effects of intervention or best-practice usual care for up to 2 years and cost utility. The outcomes should provide evidence to underpin a scalable approach to support people with newly diagnosed RA. TRIAL REGISTRATION: ACTRN12625000050459, ANZCTR. Registered on 20 January 2025.
引用
- Poulsen KA, Burton NW, Mayr HL, et al. Resilience And Healthy Lifestyle for Rheumatoid Arthritis (The RA-HEAL trial): a randomised, parallel group, placebo-controlled clinical trial protocol. Trials. 2025. PMID: 41024272. doi:10.1186/s13063-025-09063-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。